This site is intended only for healthcare professionals resident in Thailand
Menu
Close
Menu
Close
There are a number of therapeutic targets in the COVID-19 viral lifecycle:
3CLᵖʳᵒ: 3-chymotrypsin-like-protease, RNA: ribonucleic acid, RdRp: RNA-dependent RNA
polymerase
1. Binding
Prevent SARS-CoV-2 binding to the angiotensin converting enzyme 2 (ACE2) receptor:
2. Entry/exit
Inhibit viral/host interaction and endosome maturation:
3. Proteolysis
Prevent formation of proteins involved in viral replication:
4. RNA replication
Prevent replication of viral genome:
Find out more about COVID-19 diagnosis and patients who may be at high-risk of progression to severe disease.
Learn about different types of vaccines and how they may prevent disease
Adverse events should be reported. Reporting forms and information can be found at https://www.pfizersafetyreporting.com/#/en
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This website is intended only for healthcare professionals registered in Thailand. If you are a non-registered healthcare professional in Thailand wishing to access general health and medical information, please visit [www.pfizer.co.th].
This website is brought to you by Pfizer (Thailand) Limited.